Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Go behind the scenes of naming a drug

Suzanne Koven, MD
Meds
July 30, 2012
Share
Tweet
Share

One summer in college, when I couldn’t think of what else to do, I lived near campus in a punishingly hot walk up apartment, held down three boring jobs, and took intensive Latin. Every morning we met in a blissfully air-conditioned classroom–that was the upside!– to conjugate and decline: a whole year of Latin in 6 weeks. I remember nothing I learned, of course. I’m reminded of the great Woody Allen line: “I took a speed-reading course and read War and Peace in twenty minutes. It involves Russia.”

I do remember one thing I learned, though, which is that manufacturers often turn to the classics when naming products–including medications.

My Latin teacher was a young instructor who mentioned that he was supplementing his meager academic income by moonlighting with a marketing firm. His job was to use his knowledge of Latin and Greek to think up names for medications and other goods. “We want something like ‘Xerox’!” he told us the marketing firm told him. “Like ‘Xerox’!” (Xero is the Greek root meaning “dry”–xerostomia is the medical term for dry mouth–and so “Xerox” emphasized that this particular photocopy method didn’t involve wet ink–as anyone old enough to remember those sticky purple mimeographed sheets they used to hand out in school will appreciate…)

But I digress.

Every drug has at least three names. First, there’s the chemical name, then there’s the generic name, and then there is a brand name (sometimes more than one, if it’s produced by more than one company). For example, a commonly used diuretic’s chemical name is 4-chloro-N-furfuryl-5-sulfamoylanthranilic acid, its generic name is furosemide and its brand name is Lasix.

Brand names and, to a lesser extent, generic names, are chosen with great care and often at great expense. Often, as I mentioned, Latin (or, less frequently, Greek) roots are chosen to enforce, even if only subliminally, our association with the drug. Some examples:

Paxil: an antidepressant and anti-anxiety drug (Pax=peace in Latin)

Lunesta: a sleeping medication (Luna=moon in Latin)

Viagra: a medication for erectile dysfunction (Vi[r]= man in Latin and Agra=field, usually farmed or fertile in Latin and Greek)

Fosamax: a drug for osteoporosis, or bone thinning (Os=bone Max=great in Latin)

Sometimes, drug names are chosen because of the meaning their sounds imply.

For example, several drugs that regulate heart rhythm end in the suffix -olol (propranolol, atenolol, nadolol)–those two echoed syllables mimicking the beating heart.

The letters “X,” “Z,” “N,” “Q,” and “K” connote cutting edge science, which the makers of Zantac, Nexium, and Protonix (all medicines for acid reflux) wish to convey.

“S.” “M,” “V,” “L” and “R” are “soft” letters, which the names of drugs for women are likely to include. Examples are Sarafem (for pre-menstrual syndrome) and Provera and Vivelle (hormone replacements). Many birth control pills employ these letters and sort of sound like women’s first names: Junel, Alesse, Apri, Mircette, Yasmin, etc.

ADVERTISEMENT

Medications marketed to men are more likely to contain a “hard” sound like “T,” “G,” “K” or “X”–like Flomax for enlarged prostate or Levitra, for erectile dysfunction. An exception is Cialis, also for ED and with only soft syllables but with a meaningful classical root (cael=sky in Latin, also connoting “up” or “above,” as in “ceiling.”)

Even when drugs have randomly chosen names, the companies that make them seek assistance. There’s actually a website with a program, Drug-o-Matic , that generates names for pharmaceuticals.

But the frequent use of certain classical roots (“Pro,” “Uni,” “Vi,” etc.) and of certain high tech sounding letters (“X” and “Z,” especially) has led to the problem of drugs that sound alike and can be easily confused. Up to 15% of errors in drug administration are estimated to be caused by the similarity of drug names such as Celebrex (for arthritis) and Celexa (for depression) or Zocor (for high cholesterol) and Zoloft (for depression or anxiety) or Lamisil (an anti fungal) and Lamictal (an anticonvulsant and mood stabilizer). Many hospitals have initiated systems to flag such drugs. At MGH the system is called SALAD (“sound alike/look alike drugs).

Here’s an interesting article from MIT with more information about the linguistics of drug naming.

So, it turns out that some of the effects drugs have on us occur even before we open the bottle–or so pharmaceutical companies would have it.

Suzanne Koven is an internal medicine physician who blogs at In Practice at Boston.com, where this article originally appeared. She is the author of Say Hello To A Better Body: Weight Loss and Fitness For Women Over 50. 

Prev

A tragedy based on administrative decisions

July 30, 2012 Kevin 14
…
Next

Go ahead and let teens read x-rays

July 30, 2012 Kevin 16
…

Tagged as: Medications, Primary Care

Post navigation

< Previous Post
A tragedy based on administrative decisions
Next Post >
Go ahead and let teens read x-rays

ADVERTISEMENT

More by Suzanne Koven, MD

  • A hospital leader speaks out against the transgender military ban

    Suzanne Koven, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Don’t hesitate to talk to your doctor about work

    Suzanne Koven, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Patients should silence their phones in the exam room

    Suzanne Koven, MD

More in Meds

  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • The food-drug interaction risks your doctor may be missing

    Frank Jumbe
  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • Why public health must be included in AI development

      Laura E. Scudiere, RN, MPH | Tech
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • Residency match tips: Building mentorship, research, and community

      Simran Kaur, MD and Eva Shelton, MD | Education
    • From Founding Fathers to modern battles: physician activism in a politicized era [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • Why public health must be included in AI development

      Laura E. Scudiere, RN, MPH | Tech
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • Residency match tips: Building mentorship, research, and community

      Simran Kaur, MD and Eva Shelton, MD | Education
    • From Founding Fathers to modern battles: physician activism in a politicized era [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Go behind the scenes of naming a drug
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...